130 related articles for article (PubMed ID: 38184227)
21. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
22. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
23. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
Ashby LS; Smith KA; Stea B
World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
[TBL] [Abstract][Full Text] [Related]
24. Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis.
Xiao ZZ; Wang ZF; Lan T; Huang WH; Zhao YH; Ma C; Li ZQ
Front Neurol; 2020; 11():1036. PubMed ID: 33041980
[No Abstract] [Full Text] [Related]
25. Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma.
Valtorta S; Lo Dico A; Raccagni I; Martelli C; Pieri V; Rainone P; Todde S; Zinnhardt B; De Bernardi E; Coliva A; Politi LS; Viel T; Jacobs AH; Galli R; Ottobrini L; Vaira V; Moresco RM
Front Oncol; 2021; 11():664149. PubMed ID: 34012924
[TBL] [Abstract][Full Text] [Related]
26. Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.
Zoteva V; De Meulenaere V; Vanhove C; Leybaert L; Raedt R; Pieters L; Vral A; Boterberg T; Deblaere K
PLoS One; 2024; 19(3):e0300552. PubMed ID: 38489314
[TBL] [Abstract][Full Text] [Related]
27. Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis.
Qu S; Qi S; Zhang H; Li Z; Wang K; Zhu T; Ye R; Zhang W; Huang G; Yi GZ
J Exp Clin Cancer Res; 2023 Oct; 42(1):285. PubMed ID: 37891669
[TBL] [Abstract][Full Text] [Related]
28. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
29. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
30. The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review.
Alimohammadi E; Bagheri SR; Taheri S; Dayani M; Abdi A
Oncol Rev; 2020 Feb; 14(1):461. PubMed ID: 32153727
[TBL] [Abstract][Full Text] [Related]
31. Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.
Ferrer-Font L; Arias-Ramos N; Lope-Piedrafita S; Julià-Sapé M; Pumarola M; Arús C; Candiota AP
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28570014
[TBL] [Abstract][Full Text] [Related]
32. Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.
Valtorta S; Lo Dico A; Raccagni I; Gaglio D; Belloli S; Politi LS; Martelli C; Diceglie C; Bonanomi M; Ercoli G; Vaira V; Ottobrini L; Moresco RM
Oncotarget; 2017 Dec; 8(68):113090-113104. PubMed ID: 29348889
[TBL] [Abstract][Full Text] [Related]
33. Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma.
Gupta T; Selvarajan JMP; Kannan S; Menon N; Dasgupta A; Chatterjee A
Neurooncol Adv; 2023; 5(1):vdad086. PubMed ID: 37638346
[TBL] [Abstract][Full Text] [Related]
34. Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
Kim CY; Paek SH; Nam DH; Chang JH; Hong YK; Kim JH; Kim OL; Kim SH
J Neurooncol; 2020 Feb; 146(3):399-406. PubMed ID: 32020470
[TBL] [Abstract][Full Text] [Related]
35. Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials.
Fu P; He YS; Huang Q; Ding T; Cen YC; Zhao HY; Wei X
Mol Clin Oncol; 2016 May; 4(5):833-838. PubMed ID: 27123291
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Significance of O
Zhao YH; Wang ZF; Cao CJ; Weng H; Xu CS; Li K; Li JL; Lan J; Zeng XT; Li ZQ
Front Neurol; 2018; 9():127. PubMed ID: 29619003
[TBL] [Abstract][Full Text] [Related]
37. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
[TBL] [Abstract][Full Text] [Related]
38. Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
Skardelly M; Dangel E; Gohde J; Noell S; Behling F; Lepski G; Borchers C; Koch M; Schittenhelm J; Bisdas S; Naumann A; Paulsen F; Zips D; von Hehn U; Ritz R; Tatagiba MS; Tabatabai G
Oncologist; 2017 May; 22(5):570-575. PubMed ID: 28360216
[TBL] [Abstract][Full Text] [Related]
39. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
40. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
